Logo image
Validation of rapid HIV antibody tests in 5 African countries
Journal article   Open access

Validation of rapid HIV antibody tests in 5 African countries

Estelle M Piwowar-Manning, Nancy B Tustin, Physiwell Sikateyo, Debbie Kamwendo, Chifundo Chipungu, Rashika Maharaj, Jabulani Mushanyu, Barbra A Richardson, Sharon Hillier and J Brooks Jackson
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), Vol.9(3), pp.170-172
05/2010
DOI: 10.1177/1545109710368151
PMCID: PMC2989535
PMID: 20530471
url
https://doi.org/10.1177/1545109710368151View
Published (Version of record) Open Access

Abstract

The sensitivity and specificity of 3 rapid HIV antibody tests were assessed at 5 clinical trial sites in Africa and 1 site in the United States using a minimum of 100 HIV antibody positive samples and 100 HIV antibody negative samples at each site. The overall sensitivity and specificity for the OraSure OraQuick, Abbott Determine, and Trinity Unigold tests were 99.3%, 99.8%, and 98.5%, respectively, and 99.3%, 99.4%, and 99.5%, respectively. There were no instances at any site in which false-negative or false-positive results were obtained for the same sample on more than 1 rapid test kit. The results of this study provide assurance that for these diverse sites in Africa, the accuracy of these kits is quite good. Given the excellent accuracy, relatively fast turnaround time, and minimal infrastructure required, these rapid tests for HIV antibody provide a very attractive and accurate testing format.
Africa HIV Antibodies - blood HIV Infections - diagnosis Humans Reagent Kits, Diagnostic Sensitivity and Specificity

Details

Metrics

17 Record Views
Logo image